3136 results for «2735»
3136 results
A low-risk patient with a bicuspid type 0 aortic stenosis
18 May 2021 – From EuroPCR 2021
How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!
Two emergencies in one time
18 May 2021 – From EuroPCR 2021
What happened to this 47-year-old man who was still restless, hypoxic, tachypenic, and dependent on oxygen and inotrope even after excellent PCI results? Watch this session to find out more!
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
Acute STEMI, coronary ectasia and large thrombus burden
18 May 2021 – From EuroPCR 2021
In this session, discover why the combination of DOAC's and DAPT have promising role in the management of large thrombus and coronary ectasia.
Dealing with shock
18 May 2021 – From EuroPCR 2021
Find out more about left main shock syndrome, always an unpredictable situation, and study the case of a STEMI patient with cardiogenic shock.
Challenging heart failure and mitral regurgitation cases
18 May 2021 – From EuroPCR 2021
In this session, analyze the cases of a young patient with multivessel coronary disease and severe heart failure, and a patient with heart failure, prior rigid mitral ring replacement, and severe mitral regurgitation.
Mitral valve challenges
18 May 2021 – From EuroPCR 2021
Watch this session to find out more about flail bioprosthetic mitral valve treatment, acute prosthetic mitral valve regurgitation, severe structural and non-structural mitral bioprosthesis degeneration, and severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement
Uncrossable lesions
18 May 2021 – From EuroPCR 2021
Thanks to this session, get to know how to treat an uncrossable lesion, and especially in patients with inferior STEMI.
Surgery or PCI?
18 May 2021 – From EuroPCR 2021
In this session, discover a case when the surgeon ́s ambitions are higher than his courage.
Which way to choose?
18 May 2021 – From EuroPCR 2021
Watch this video to check whether you would have opted for the same vessel and the same strategy when facing this NSTEMI case.
Emergency cases in the cathlab: there is not just ACS and PCI
18 May 2021 – From EuroPCR 2021
Look at this video presenting a patient with massive bilateral central pulmonary embolism: how would you treat?
TAVI procedure optimisation with the cusp overlap technique
27 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...
Addressing the challenges of small annuli patients with the Evolut Platform
27 Sep 2021 – From PCR Tokyo Valves 2021
Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...
Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology
27 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...
Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY
18 May 2021 – From EuroPCR 2021
Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...
XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES
18 May 2021 – From EuroPCR 2021
Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.
EBC Main: Behind the curtain
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith in order to have additional information about the EBC main trial, to learn about the principal investigator's interpretation of results, and to find out about the European Bifurcation Club's remaining questions to be addressed in future trials.
Single vs. two-stent techniques in left main: the impact of EBC MAIN
18 May 2021 – From EuroPCR 2021
Watch this video presented by Goran Stankovic, Tom Johnson, David Hildick-Smith, Jens Flensted Lassen, Gabor G. Toth and Junjie Zhang in order to understand the results of EBC MAIN and the impact to clinical practice, to discuss the EBC MAIN outcomes of one- vs. two-stent technique, and to hear...
The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
